No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: interim results from the PURE01 study

التفاصيل البيبلوغرافية
العنوان:	No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: interim results from the PURE01 study
المؤلفون:	G. Basile, M. Bandini, E. Zaffuto, S. Scuderi, F. Pederzoli, L. Marandino, D. Raggi, F. Barletta, G. Gandaglia, N. Fossati, G. Burgio, M. Moschini, S. Zamboni, L. Afferi, S. Comana, A. Briganti, F. Montorsi, R. Colombo, A. Necchi, A. Gallina
المصدر:	European Urology Open Science, Vol 20, Iss , Pp S168- (2020)
بيانات النشر:	Elsevier, 2020.
سنة النشر:	2020
المجموعة:	LCC:Diseases of the genitourinary system. Urology LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية:	Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2666-1683
Relation:	http://www.sciencedirect.com/science/article/pii/S2666168320356172; https://doaj.org/toc/2666-1683
DOI:	10.1016/S2666-1683(20)35617-2
URL الوصول:	https://doaj.org/article/57e9850a71fd4929943d595a4f8c1fb1
رقم الأكسشن:	edsdoj.57e9850a71fd4929943d595a4f8c1fb1
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	26661683
DOI:	10.1016/S2666-1683(20)35617-2